March 5, 2019 — The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not…Original Article
FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression
